Rapid Quantification of Isomeric & Dehalogenated Impurities in Pharmaceutical Raw Materials Using MRR Spectroscopy
Originally Published in the Journal of Pharmaceutical & Biomedical Analysis, September 2020
Authors: Justin L. Neill; Alexandar V. Mikhonin; Ted Chen; Reilly E. Sonstrom; Brooks H. Pate
Publication Summary
Originally published in the Journal of Pharmaceutical and Biomedical Analysis, this publication demonstrates how molecular rotational resonance (MRR) spectroscopy can rapidly identify and quantify isomeric, dehalogenated, and enantiomeric impurities in pharmaceutical raw materials. The study focuses on compounds used in the synthesis of the HIV integrase inhibitor cabotegravir, where accurate impurity characterization is critical for maintaining product quality and preventing structurally similar impurities from carrying through to the final drug product.
The researchers show that MRR spectroscopy can perform highly selective impurity analysis without the need to develop chromatographic separation methods. Using both broadband and targeted MRR approaches, the study demonstrates rapid quantification of multiple impurity types and validates the technique's ability to support pharmaceutical quality assessment. The results highlight MRR's potential to simplify analytical workflows while delivering precise structural and quantitative information.
Key Takeaways
-
MRR spectroscopy enables rapid quantification of isomeric, dehalogenated, and enantiomeric impurities in pharmaceutical raw materials.
-
The technique can distinguish structurally similar compounds with high specificity, making it well-suited for impurity analysis and quality control applications.
-
Chromatographic method development is not required, helping reduce analytical complexity and accelerate testing workflows.
-
Both broadband and targeted MRR approaches were successfully applied, providing a pathway from compound identification to rapid routine analysis.
-
The methodology demonstrated quantitative performance across relevant impurity concentration ranges, supporting its use for pharmaceutical quality assessment.
-
The study highlights MRR as a powerful tool for validating pharmaceutical raw material purity, combining structural specificity with efficient quantitative analysis.